Back

Mortality in patients implanted with cardiac resynchronisation therapy with or without a defibrillator

23 May 2016 (14:51 - 14:57)
Organised by:
Congress Presentation Part of: Rapid Fire 4 - Devices Cardiac resynchronisation therapy HFA Premium Access HEART FAILURE 2016

About the speaker

Photo
Doctor Shveta Monga

University of Oxford, Oxford (United Kingdom of Great Britain & Northern Ireland)

14 More presentations in this session

Presentation thumbnail
Non-invasive lung impedance-guided preemptive treatment in chronic heart failure patients: a randomized controlled trial (impedance-HF trial)
Professor M. Kleiner Shochat (Hadera, IL)
Abstract Slides
Presentation thumbnail
Diagnostic relevance of diastolic stress-test echocardiography in patients with suspicion of heart failure with preserved ejection fraction
Doctor E. Belyavskiy (Berlin, DE)
Abstract Slides
Presentation thumbnail
Left ventricular dimension, but not reverse remodeling, predict the occurrence of malignant ventricular tachyarrhythmias in CRT patients.
Doctor A. Paoletti Perini (Florence, IT)
Abstract Slides
Presentation thumbnail
Axial-flow left ventricular assist device pump speed increase is associated with increased peak exercise cardiac output and VO2, postponed anaerobic threshold and improved ventilatory efficiency
Doctor A. Del Torto (Milano, IT)
Abstract Slides
Presentation thumbnail
The heart mate risk score identifies patients with similar mortality risk across all INTERMACS classes in a large multicenter analysis: low INTERMACS class should not be a contraindication to LVAD
Doctor L. Adamo (St Louis, US)
Abstract Slides

Access the full session

Session thumbnail
Rapid Fire 4 - Devices

The Event

Event poster

HEART FAILURE 2016

23 May 2016 14:51 CET

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources